James Armitage, M.D.

armitageJames Armitage, M.D.
The Joe Shapiro Professor of Medicine
Division of Oncology & Hematology

Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax 402-559-6520

Practice locations:
The Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Nebraska Medicine Village Point
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100 (map)

Education:
University of Nebraska Medical Center, Omaha, NE, Intern, (1974)
University of Nebraska Medical Center, Omaha, NE, Resident, (1975)
University of Nebraska, Lincoln, NE, B.S., (1969)
University of Nebraska Medical Center, Omaha, NE, M.D., (1973)
University of Iowa Hospitals and Clinics, Iowa City, IA, Fellow, (1977)

Hospital Appointments:
Nebraska Medicine

Interests:
Non-Hodgkin Lymphoma, Hodgkin Disease, Chronic Lymphocytic Leukemia

Membership in Societies:
ASCO; ASH, ASBMT, ACP, AAP, Royal College of Physicians

Biographical Sketch:
Dr. James O. Armitage graduated from the University of Nebraska Medical Center in 1973 where he completed his internship and residency in internal medicine in 1975. In 1977 he completed a fellowship in hematology-oncology at the University of Iowa Hospitals and Clinics, Iowa City, Iowa. Dr. Armitage was in private practice from 1977-79, and in 1979 he returned to the University of Iowa as an Assistant Professor of Medicine, where he developed and was director of the Bone Marrow Transplantation Program. In 1982 he returned to Nebraska as as Associate Professor of Medicine and was promoted in 1987 to Professor of Medicine. He has served as Vice Chairman of the Department of Medicine (1982-90), Chief of the Division of Oncology/Hematology (1986-89), Chairman of the Department of Internal Medicine (1990-99), Dean, College of Medicine (2000-03), and presently holds the position of the Joe Shapiro Professor of Medicine. He is a member of several professional organizations as well as an editor of the ASCO publications ASCO Post and Journal of Oncology Practice.  He is a Fellow of the American College of Physicians, the Royal College of Physicians and ASCO.  He has served as President of ASCO (1996-97) and President of ASBMT (2000-01). He has authored or co-authored over 500 articles, over 100 book chapters, and is the editor/co-editor of 27 books. He is married to Nancy Armitage and the father of four children and grandfather of eleven grandchildren.

Select Publications:
Armitage JO, Longo DL, Is watch and wait still acceptable for patients with low grade follicular lymphoma? Blood 2016; 127(23): 2804-2808

Armitage JO, Wood WC, Longo DL, Real personalized medicine; J Natl Compre Canc Netw 2016; 14(2): 233-236

Longo DL. Armitage, JO, Controversies in the treatment of early-stage Hodgkin lymphoma, N Eng J Med 2015; 372(17): 1667-1669

Smith TJ, Bohlke K, Armitage JO, Recommendations for the use of white blood cell growth factors:  American Society of Clinical Oncology Clinical Practice Guideline Update, J Clin Oncol 2015; 33(28): 3199-3212

Bennett CL, Chen B, Hermanson T, Wyatt MD, Schulz RM, Georgantopoulos P, Kessler S, Raisch DW, Quershi ZP, Lu ZK, Love BL, Noxon V, Bobolts L, Armitage M, Bian J, Ray P, Ablin RJ, Hrushesky WJ, Macdougall IC, Sartor O, Armitage JO, Regulatory and clinical considerations for biosimilar oncology drugs, Lancet Oncol, 2014; 15(13): e594-605

Bennett CL, Djulbegovic B, Norris LB, Armitage JO:  Clinical Therapeutics:  Colony-stimulating factors for febrile neutropenia in the cancer setting.  New Engl J Med 2013; 368 (12):1131-1139

Dispenzieri A, Armitage JO, Loe MJ, Geyer S, Allred J, Camoriano J, Menke DM, Weisenburger D, Ristow K, Dogan A, Weisenburger DD. The clinical spectrum of Castleman’s Disease. American Journal of Hematology 2012; 87(11): 997-1002

Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed